Entering text into the input field will update the search result below

Stocks To Watch: Eyes On CES, OPEC+ And Electric Vehicle Deliveries

Jan. 01, 2022 9:53 AM ETAdvanced Micro Devices, Inc. (AMD), NIO, GM, GHC, EWTXFDS7 Comments
SA Stocks To Watch profile picture
SA Stocks To Watch

Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentations.

To catch up on what you may have missed this week, watch Saturday's Alpha TALKS episode or listen to the podcast, part of Wall Street Breakfast, our flagship daily newsletter delivering everything you need to know each day. Stocks to Watch subscribers can also tune in on Sundays for a curated podcast that's available on Seeking Alpha, Apple Podcasts, Stitcher and Spotify.

The first trading week of 2022 will include an important OPEC+ meeting, the release of the minutes from the last Federal Open Market Committee meeting and the December jobs report. Strong deliveries updates from Chinese electric vehicle makers Nio (NYSE:NIO), XPeng (XPEV), Li Auto (LI) just reported today could give EV stocks a jolt. Tesla (TSLA) is also due to update on quarterly deliveries sometime during the first few days of the month. Also watch for December traffic reports from airlines such as American Airlines Group (AAL), Delta Air Lines (DAL), United Airlines (UAL), Southwest Airlines (LUV), Spirit Airlines (SAVE) and JetBlue (JBLU). Those updates from the carriers could include new Q4 guidance to factor in the impact of Omicron and operational disruptions.

Earnings spotlight: Wednesday - January 5 Jefferies (JEF).

Earnings spotlight: Thursday - January 6 Bed, Bath & Beyond (BBBY), Walgreen Boots Alliance (WBA), Constellation Brands (STZ), PriceSmart (PSMT) and Conagra Brands (CAG).

IPO watch: IPOs expected to start trading include Cingulate (CING), HashiCorp (HCP), Nu Holdings (NU) and Chicago Atlantic Real Estate Finance (REFI).

CES preview: One of the biggest tech conferences of the year takes place in Las

This article was written by

SA Stocks To Watch profile picture
Our news team's weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks.

Recommended For You

Comments (7)

Jan 28Feb 2Feb 7Feb 10Feb 15Feb 18Feb 24
sportssam8 profile picture
2022 should be an interesting year. I expect both growth and value stocks to do well, but the high multiple large cap growth stocks will continue to be under pressure.

I am going to look into adding to my holdings in $MPW early next week, and I think I will initiate a position in $AMKR to add diversification to my portfolio.

Best of luck to all in 2022!
Best time to NOT buy penny garbage stocks is now. Don't
throw money away.
@AlieGee penny stonks should only be played with fun money. like going to Vegas and throwing down a few stacks on black or red
johnsoriaknows profile picture
Bargains galore next week....but probably won't last long. The best time to buy however was the last week of 2021 when tax selling went up a notch.

The best bargains are probably in the biotech sector, and nanocaps in particular, which were severely and undeservedly abused in 2021 helped in the latter part of the year in part by overblown Omicron speculations/fear and also by tax selling season. I expect this sector to bounce violently starting next week. One of the stocks with greatest upside in this sector is BiolineRX (BLRX) which analysts project a 700%++ gain in 2022 because of likely drug approval and the various catalysts leading to it.

Here is more information for those curious about this opportunity:


For those who like penny stocks with high upside, Synthetic Biologics (SYN) trading 40% lower than cash on hand and having a potentially monster pipeline with many near-term catalysts, it offers a potential 500%++ gain in1H 2022. Here is more information on this opportunity:


In both cases technicals look horrible now but I expect a significant inflection going forward.

Happy New Year to everyone reading this and your loved ones!
@johnsoriaknows I still see further downside on biotech and nanocaps before a bounce. Almost time to buy, but not yet.
johnsoriaknows profile picture
@Nukems Thank your for your comment. Realistically, there could be downside on most sectors, but among them you will find a few extremely undervalued plays offering a huge reward to risk ratio because of known near-term upcoming catalysts. The ones I mentioned are two of them but there are hundreds more out there....just have to do a lot of DD to uncover off-the-radar diamonds on the rough.
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.